FABBRI, Leonardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 55.679
AS - Asia 22.812
EU - Europa 22.707
SA - Sud America 2.447
Continente sconosciuto - Info sul continente non disponibili 517
AF - Africa 424
OC - Oceania 117
Totale 104.703
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 54.921
GB - Regno Unito 8.171
CN - Cina 6.954
SG - Singapore 6.609
IT - Italia 4.643
HK - Hong Kong 2.834
SE - Svezia 1.879
BR - Brasile 1.866
FI - Finlandia 1.857
DE - Germania 1.615
VN - Vietnam 1.605
UA - Ucraina 1.406
BD - Bangladesh 1.310
TR - Turchia 1.072
FR - Francia 802
RU - Federazione Russa 779
KR - Corea 694
BG - Bulgaria 510
CA - Canada 396
IN - India 391
ID - Indonesia 267
NL - Olanda 214
AR - Argentina 197
IQ - Iraq 177
IE - Irlanda 176
MX - Messico 166
JP - Giappone 144
PK - Pakistan 116
ZA - Sudafrica 109
AU - Australia 106
PL - Polonia 92
CO - Colombia 89
AE - Emirati Arabi Uniti 70
CL - Cile 69
ES - Italia 69
BE - Belgio 68
RO - Romania 65
EC - Ecuador 63
MY - Malesia 57
AT - Austria 56
EG - Egitto 54
VE - Venezuela 51
TH - Thailandia 50
PH - Filippine 48
SA - Arabia Saudita 47
MA - Marocco 46
UZ - Uzbekistan 45
CH - Svizzera 43
IR - Iran 41
NP - Nepal 39
TN - Tunisia 38
PY - Paraguay 37
CR - Costa Rica 36
EU - Europa 36
JM - Giamaica 36
PT - Portogallo 34
JO - Giordania 31
NG - Nigeria 30
PE - Perù 29
TW - Taiwan 28
KE - Kenya 27
UY - Uruguay 27
CZ - Repubblica Ceca 24
AZ - Azerbaigian 23
RS - Serbia 23
AL - Albania 22
HN - Honduras 22
OM - Oman 22
DZ - Algeria 20
SI - Slovenia 20
BY - Bielorussia 19
DK - Danimarca 18
IL - Israele 18
LT - Lituania 18
BO - Bolivia 17
ET - Etiopia 16
NI - Nicaragua 16
BH - Bahrain 14
LB - Libano 14
GT - Guatemala 13
KZ - Kazakistan 13
SY - Repubblica araba siriana 13
AO - Angola 12
HR - Croazia 12
KG - Kirghizistan 12
SN - Senegal 12
DO - Repubblica Dominicana 11
PR - Porto Rico 11
TT - Trinidad e Tobago 10
BS - Bahamas 9
HU - Ungheria 9
LV - Lettonia 9
PA - Panama 9
GE - Georgia 8
MD - Moldavia 8
QA - Qatar 8
BA - Bosnia-Erzegovina 7
CI - Costa d'Avorio 7
EE - Estonia 7
GR - Grecia 7
Totale 104.070
Salva come PNG Salva come JPEG
Città #
Southend 6.009
Fairfield 5.795
Ashburn 4.906
Woodbridge 4.243
Singapore 4.198
Santa Clara 3.277
Houston 3.100
Jacksonville 3.096
Hefei 2.808
Hong Kong 2.779
Chandler 2.263
Seattle 2.086
Dearborn 1.993
Wilmington 1.990
Cambridge 1.901
Ann Arbor 1.870
San Jose 1.676
Helsinki 1.353
London 1.300
Beijing 1.086
Nyköping 900
The Dalles 786
Los Angeles 756
Chicago 745
Council Bluffs 726
Modena 679
Seoul 638
San Diego 588
New York 584
Princeton 556
Milan 544
Izmir 503
Sofia 499
Des Moines 496
Eugene 484
Ho Chi Minh City 480
Hanoi 403
Lauterbourg 397
Buffalo 353
Columbus 326
Rome 312
Salt Lake City 296
Dallas 256
Moscow 223
Shanghai 182
Dublin 173
São Paulo 169
Tampa 151
Elk Grove Village 129
Phoenix 126
Frankfurt am Main 121
Jakarta 118
Redwood City 118
Falls Church 116
Boardman 102
Palermo 101
Tokyo 101
Naples 100
Guangzhou 97
Norwalk 97
Atlanta 94
Da Nang 87
Toronto 86
Miano 84
Nanjing 84
Kent 83
Grafing 77
North Bergen 76
Warsaw 75
Sterling 72
San Francisco 71
Brooklyn 69
Orem 67
Haiphong 65
Baghdad 64
Bari 63
Kunming 61
Lancaster 61
Miami 59
Amsterdam 57
Chennai 57
Mexico City 57
Falkenstein 56
Charlotte 55
Verona 55
Bologna 54
Philadelphia 53
Montreal 50
Boston 49
Mumbai 49
Turin 48
Jersey City 47
Jinan 47
Brussels 45
Kilburn 45
Rio de Janeiro 45
Wuhan 45
Detroit 44
Florence 44
Washington 42
Totale 74.702
Salva come PNG Salva come JPEG
Nome #
Medicina Interna Sistematica 2.119
Asma bronchiale 667
Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: A randomized noninferiority trial 494
The Burden of Image Based Emphysema and Bronchiolitis in HIV-Infected Individuals on Antiretroviral Therapy 488
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary 482
Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study 461
Clinical use of Levofloxacin in the long-term treatment of drug resistant tuberculosis. 458
Taking Aim at Asthma Around the World: Global Results of the Asthma Insight and Management Survey in the Asia-Pacific Region, Latin America, Europe, Canada, and the United States 430
T cell-based tracking of multidrug resistant tuberculosis infection after brief exposure 411
Performance of tests for latent tuberculosis in different groups of immunocompromised patients 407
Three-year hospitalization and mortality in elderly smokers with COPD or CHF. 393
Clusterin decreases oxidative stress in lung fibroblasts exposed to cigarette smoke 389
Effects of a walking aid in COPD patients receiving oxygen therapy 385
Beclometasone–formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial 375
Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial 368
T-cell-based diagnosis of neonatal multidrug-resistant latent tuberculosis infection. 364
Short-Term Efficacy of Upper-Extremity Exercise Training in Patients With Chronic Airway Obstruction: A Systematic Review. 358
Diagnosis of occult tuberculosis in hematological malignancy by enumeration of antigen-specific T cells. 356
Chronic Lung Disease in HIV Patients 353
Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial 346
Role of chemotherapy and the receptor tyrosine kinases KIT, PDGFR alpha, PDGFR beta, and met in large-cell neuroendocrine carcinoma of the lung 339
Cellular and structural bases of chronic obstructive pulmonary disease 337
Treatment of chronic obstructive pulmonary disease and its comorbidities 335
Roflumilast:un nuovo farmaco per il trattamento della BPCO 334
Update in Chronic Obstructive Pulmonary Disease 2005 333
La broncopneumopatia cronica ostruttiva nell'anziano 332
Comparison of the tubercolin skin test and the ellispot blood test for the diagnosis of latent tuberculosis infection in pre-transplant dialysis patients 330
Exacerbation of respiratory Symptoms in COPD patients may not be exacerbations of COPD 326
Association between HLA genes and susceptibility to toluene diisocyanate-induced asthma 326
From COPD to chronic systemic inflammatory syndrome? 325
Complex chronic co-morbidities of COPD 323
Role Of The QFT-IT Assay For The Diagnosis Of Latent Tuberculosis Infection Among Adult Immigrants 323
Inhaled Corticosteroids in COPD: Pros and Cons. 321
Use of adjunctive cardiovascular therapy in patients hospitalized for acute exacerbations of COPD. 320
Echocardiography, Spirometry, and Systemic Acute-Phase Inflammatory Proteins in Smokers with COPD or CHF: An Observational Study 320
Update in chronic obstructive pulmonary disease 2006 318
Acute exacerbations of chronic obstructive pulmonary disease provide a unique opportunity to take care of patients 316
Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma 314
Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: Two randomised clinical trials 311
Chronic critical illness: the price of survival 310
Macrolides in the treatment of asthma and cystic fibrosis 309
Polymorphisms in IL13 pathway genes in asthma and chronic obstructive pulmonary disease 309
Breakthroughs in internal and respiratory medicine 309
Prognostic role of clusterin in resected adenocarcinomas of the lung. 306
Triggering receptor expressed on myeloid cells: role in the diagnosis of lung infections 306
Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials 306
Transforming growth factor-β type II receptor in pulmonary arteries of patients with very severe COPD 305
Clusterin (CLU) and lung cancer 304
Uniform definition of asthma severity, control, and exacerbations: Document presented for the World Health Organization Consultation on Severe Asthma. 304
Home Oxygen Saturation Monitoring And Quality Of Life Evaluation In Patients With Idiopathic Pulmonary Fibrosis: Preliminary Results From A Prospective Multicenter Trial 303
Insufficienza Respiratoria acuta e cronica (cap.21). 302
Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations 300
Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma 299
Effectiveness of erdosteine in elderly patients with bronchiectasis and hypersecretion: A 15-day, prospective, parallel, open-label, pilot study 298
Early diagnosis of subclinical multi drug-resistant tuberculosis 298
Benralizumab: for asthma, not yet for COPD 297
Mechanisms of acute exacerbation of respiratory symptoms in chronic obstructive pulmonary disease 297
Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation 294
Cardiovascular mechanisms of death in severe COPD exacerbation: time to think and act beyond guidelines 292
Sarcoidosis: challenging diagnostic aspects of an old disease. 291
Pathophysiology of exacerbations of chronic obstructive pulmonary disease 290
Tiotropium versus salmeterol for the prevention of exacerbations of COPD 287
How to Integrate Multiple Comorbidities in Guideline Development 286
Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease. 286
Activated T-lymphocytes and eosinophils in the bronchial mucosa in isocyanate-induced asthma. 282
Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial 281
Quantiferon-TB Gold In-Tube Tests In Hospital Health Care Workers: A Five Years Experience 281
Mechanisms of bradykinin-induced contraction in human fetal lung fibroblasts. 278
Poor adherence to guidelines for long-term oxygen therapy (LTOT) in two Italian university hospitals. 278
Comparative efficacy of once-daily ciclesonide and budesonide in the treatment of persistent asthma 277
Link between chronic obstructive pulmonary disease and coronary artery disease: implication for clinical practice 276
Performance of commerical blood tests for the diagnosis of latent tuberculosis infection in children and adolescents 276
Airflow limitation in chronic bronchitis is associated with T-lymphocyte and macrophage infiltration of the bronchial mucosa 275
Home-centred physical fitness programme in morbidly obese individuals: a randomized controlled trial 275
Summary of recommendations for the design of clinical trials and the registration of drugs used in the treatment of asthma 274
Chronic disease in the elderly: back to the future of internal medicine. 274
COPD and the Solar System:Introducing the Chronic Obstructive Pulmonary Disease Comorbidome 274
Asthma in the elderly: what we know and what we have yet to know 270
Systems medicine approaches for the definition of complex phenotypes in chronic diseases and ageing. From concept to implementation and policies 269
Association between markers of emphysema and more severe chronic obstructive pulmonary disease 267
Efficacy of standard Rehabilitation in COPD Outpatients with Co-morbidities. 266
Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial 266
Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. 265
Significant chronic airway abnormalities in never-smoking HIV-infected patients 265
Airway mucosal inflammation in occupational asthma induced by toluene diisocyanate 264
Corticosteroid inhibition of airway microvascular leakage. 263
Adjustable maintenance dosing with budesonide/formoterol in a single inhaler provides effective asthma symptom control at a lower dose than fixed maintenance dosing 263
Eosinophilia in asthma: the easy way is not always the best 263
Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial) 262
An official American Thoracic Society/European Respiratory Society statement: research questions in chronic obstructive pulmonary disease 258
Cytokines in the airway mucosa of subjects with asthma induced by toluene diisocyanate. 257
Effects of unsupported upper extremity exercise training in patients with COPD: A randomized clinical trial 257
Blood tests for diagnosis of tuberculosis - Reply 255
Actions other than smooth muscle relaxation may play a role in the protective effects of formoterol on the allergen-induced late asthmatic reaction. 255
The distribution of neurokinin-1 and neurokinin-2 receptors in human central airways. 255
Effects of early inpatient rehabilitation after acute exacerbation of COPD 255
Use of a T-cell interferon-γ release assay for the diagnosis of tuberculous pleurisy 255
Phosphodiesterase-4 Inhibitor Therapy for Lung Diseases 255
Airway eosinophilia in chronic bronchitis during exacerbations. 253
Mycobacterium tuberculosis induces CCL18 expression in human macrophages 253
Totale 33.367
Salva come PNG Salva come JPEG
Categoria #
all - tutte 410.768
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 410.768
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20228.180 0 1.276 963 673 216 357 636 409 851 561 1.330 908
2022/20236.892 803 496 362 556 845 1.260 116 733 1.035 118 316 252
2023/20244.221 176 311 297 440 772 440 423 530 148 122 143 419
2024/202514.078 611 264 175 868 2.559 1.611 887 778 1.851 905 1.727 1.842
2025/202629.793 1.693 1.357 3.209 2.727 3.304 2.789 4.155 1.475 2.387 2.222 2.488 1.987
2026/20272.127 1.223 904 0 0 0 0 0 0 0 0 0 0
Totale 104.703